Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
From TechCrunch
By Marina Temkin
May 15, 2024
For years, Sammy Faycurry has been hearing from his dietician mom and sister about how poorly many Americans eat and their struggles with delivering nutritional counseling.
Although nearly half of all adults in the country are affected by chronic conditions linked to unhealthy diets, health plans have a limited number of in-network registered dieticians.
Faycurry decided to build a platform that would empower RDs, like his mom and sister, to start their own practices while being covered by insurance.
He began working on Fay, a startup that connects RDs with insurances and patients, when he was an MBA student at Harvard Business School in 2021. About a year into his effort, which Faycurry initially bootstrapped, he asked Mark Stefanski to join him as a CTO.
On Wednesday, Fay emerged from stealth after quietly raising $25 million from General Catalyst and Forerunner Ventures, with participation from 1984 and the founders of Grow Therapy and Maven Clinic.
Fay offers RDs a franchise model that has gained popularity among certain types of healthcare providers in recent years. The so-called business-in-box gives practitioners, such as dietitians and therapists, the tools for running their practices, including filing claims with insurance, receiving payments and being matched with patients.
“Insurance companies love it because their patients are getting healthier. And the dietitians love it because they can make almost five to eight times more money as independent practitioners with our platform than they earn in a hospital,” Faycurry told TechCrunch.
Other startups that have implemented this business model include Grow, a network for therapists that last month raised an $88 million Series C led by Sequoia and Nourish, which, just like Fay, matches RDs with patients. Nourish closed its $35 million Series A in March in a round led by Index Ventures.
Fay currently has 1,000 RDs on its platform and allows people covered by Anthem, United Healthcare, Aetna CVS, Blue Cross, Cigna, Optum, Humana, and other insurance providers to use their services weekly or bi-weekly for a price of a regular co-payment.
“Payers and employers’ costs have been skyrocketing for a long time. Everyone’s saying diet, diet, diet, and then no one has been doing anything about it,” Faycurry said.
Curiously, many of Fay’s patients are people who take Ozempic and other GLP-1 medicines, which are currently being touted as miracle weight loss drugs. That’s because doctors who prescribe these medications require patients to see a dietician so they learn healthy habits. “We’ve seen people who lost 25 pounds, but they still have high cholesterol because they’re having a slice of bacon with every meal,” Faycurry said.
Nicole Johnson, a partner at Forerunner Ventures, said that her firm was impressed with Fay’s execution. “They got off to a really quick start and grew revenues at an incredibly fast pace while burning very little capital.” And Fay has big plans for future expansion into meal delivery, too, Johnson said.
Get inside Disrupt: Volunteer at TechCrunch Disrupt 2025
TechCrunch Disrupt 2025 lands in San Francisco this October, and if you’re eager to break into the tech world, here’s your chance to be in the room where it all happens. We’re looking for curious, driven volunteers to join our team at Moscone West from October 27–29, and help power one of the most iconic startup events in the world. There’s no better way to experience Disrupt and learn from the best You’ll do more than just lend a hand. As a volunteer, you’ll get a behind-the-scenes look at the
Jul 29, 2025
Do startups still need Silicon Valley? Hear from the founders and funders challenging old assumptions at TechCrunch Disrupt 2025
As the startup world descends on San Francisco for TechCrunch Disrupt 2025 — happening October 27-29 at Moscone West — one question looms large: Does building in Silicon Valley still give founders an edge? With 10,000+ startup and VC leaders gathering for this milestone Disrupt, the conversation around access, geography, and opportunity has never been more timely. On the Builders Stage, Anh-Tho Chuong (Lago), David Hall (Revolution), and Heather Doshay (SignalFire) lead a must-attend session fo
Jul 28, 2025
Meet the minds shaping AI: TechCrunch Disrupt 2025 AI Stage revealed
At TechCrunch Disrupt 2025, the AI Stage comes alive with the voices shaping the future of technology, creativity, and security. Top VCs reveal what it takes to win funding in a rapidly evolving landscape, as they place bets on the next wave of AI founders. Hear groundbreaking insights from leaders at visionary startups like Apptronik, ElevenLabs, Hugging Face, Runway, Wonder Dynamics, Writer, and Wayve — pioneers redefining the future of tech. These leaders, and many more below, represent the
Jul 28, 2025